Abstract: The present invention provides a vaccine against Lyme disease, wherein it contains one or more monoclonal antibodies which are specific for the 31 kD antigen (OspA) or the 34 kD antigen (OspB) of Borrelia burgdorferi. The present invention also provides a process for obtaining this vaccine, as well as new monoclonal antibodies and antigens.
Type:
Grant
Filed:
October 7, 1999
Date of Patent:
September 2, 2003
Assignees:
Max-Planck-Gessellschaft zur förderung der
Wissenschaften e.V., Deutsches Krebsforschun zentrum Stiftung des
öffentlichen Rechts
Inventors:
Markus M. Simon, Ulrich E. Schaible, Klaus Eichmann, Michael Kramer, Wallich Reinhard